COVID-19 Continues To Shape MTI 100 Entering 2022

In this special podcast, Medtech Insight commercial/R&D editor Reed Miller talks to In Vivo executive editor Ashley Yeo about the annual MTI 100 list and the major trends facing the top medtech companies entering the third year of the pandemic. Related articles: https://medtech.pharmaintelligence.informa.com/datasets/company-rankings-2022 https://medtech.pharmaintelligence.informa.com/MT144758/MTI-100-Review-Medtechs-Drive-To-Keep-The-Status-Quo-In-A-Year-Like-No-Other https://medtech.pharmaintelligence.informa.com/MT144772/MTI-2022-Outlook-The-PostCOVID-Mantra-For-Medtechs-Prioritize-Optimize-And-Modernize https://medtech.pharmaintelligence.informa.com/MT144780/MTI-100-2022-Big-Cardio-Medtechs-Are-Moving-ESG-Agenda-To-Center-Stage